Atezolizumab for Lung Cancer Treatment Lung cancer is a leading cause of cancer death at a global level. Atezolizumab, trade name Tecentriq, is indicated for patients with metastatic non-small cell lung cancer…
Month: January 2017
Drug: Alecensa (Alectinib) to Treat NSCLC
Alecensa (Alectinib) – FDA Approved Lung cancer is one of the leading causes of cancer deaths. Alecensa (alectinib) is an FDA approved drug for the treatment of non-small cell lung cancer (NSCLC)….
Drug: Afinitor (Everolimus) to Treat NSCLC
Everolimus for Lung Cancer Treatment Everolimus in combination with pemetrexed is used in treatment of non-small cell lung cancer (NSCLC). The US brand name of everolimus is Afinitor. It is approved for…
Drug: Afatinib Dimaleate to Treat NSCLC
Treatment of Lung Cancer Lung cancer is a type of cancer that starts in lungs and those who smoke have a higher risk of having this disease. The best way smokers can…
Drug: Abitrexate (Methotrexate) to Treat NSCLC
Here, we emphasize the use of drugs to treat non-small cell lung cancer. One of the useful drugs among them is Methotrexate. It is used to treat some cancer of skin, breast…